3-azidopyrimethamine has been researched along with Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blackledge, GR; Crawford, SM; Hoffman, R; Newlands, ES; Slack, J; Stevens, MF; Stuart, NS | 1 |
1 other study(ies) available for 3-azidopyrimethamine and Neoplasms
| Article | Year |
|---|---|
A phase I study of meta-azidopyrimethamine ethanesulphonate (MZPES)--a new dihydrofolate reductase inhibitor.
Topics: Antineoplastic Agents; Azides; Dose-Response Relationship, Drug; Drug Evaluation; Folic Acid Antagonists; Humans; Infusions, Intravenous; Neoplasms; Pyrimethamine; Pyrimidines | 1989 |